Clinical Trial Update: Multicenter, Prospective Study to Determine the Performance and Safety of the New M-HA30 Architect Device on the Quality of the Skin: HEBE8 Study [NA]

View source ↗

Summary

This multicenter prospective study evaluated the performance and safety of the M-HA30 Architect Device for improving skin quality in individuals with skin aging…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Skin Aging

Drugs mentioned

• M-HA30 Architect Device

Snippet

Sponsor: Laboratoires FILLMED | Conditions: Skin Aging | NA | Status: COMPLETED